Zosyn 3.375 GM/50 ML galaxy 50ML
Ended Awarded Last action
- Contract number
- SPE2DR26FHGV6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,626
Award facts
- Contract value 100% obligated
- $1,626.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,626.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Zosyn 3.375 GM/50 ML Galaxy 50ML. This firm fixed-price delivery order, issued on December 22, 2025, is scheduled for ultimate completion by January 14, 2026, with no set-aside designation applied. The award utilizes DMS Pharmaceutical Group's existing Indefinite Delivery Contract under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish regional prime vendor contractors supporting Department of Defense medical supply needs globally.
DMS Pharmaceutical Group has demonstrated substantial federal contracting capability through its comprehensive pharmaceutical distribution portfolio, which includes branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables. The company holds a single-award IDC under PPV-G GEN V designated as contract SPE2DR, awarded on November 13, 2025, with a $499.999 billion ceiling value and completion date of December 31, 2036. This delivery order for Zosyn, an antibiotic pharmaceutical, represents one of numerous orders issued by the Defense Logistics Agency's Medical Supply Chain division to support recurring medical supply requirements of military healthcare facilities worldwide, reflecting DMS Pharmaceutical Group's established performance and competitive capability in unrestricted federal pharmaceutical procurement.
Quick answers
Who was awarded contract SPE2DR26FHGV6?
SPE2DR26FHGV6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FHGV6 worth?
The government has obligated $1,626 on SPE2DR26FHGV6.
Is contract SPE2DR26FHGV6 an order under another contract?
Yes. SPE2DR26FHGV6 is a delivery order under SPE2DR25D9244, an indefinite delivery contract.
Was contract SPE2DR26FHGV6 competed?
The extent of competition for SPE2DR26FHGV6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award